Endoscopic Nd: YAG laser with aggressive multimodality therapy for locally advanced esophageal cancer

Gastrointestinal Endoscopy

Volumn 55, Issue 6, 2002, Pages 674-679

  Alexander, Pendleton ^a   Mayoral, William ^a   Reilly, Harold F ^a   Wadleigh, Robert ^a   Trachiotis, Gregory ^a   Lipman, Timothy O ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS CANCER; FEMALE; HUMAN; LOW LEVEL LASER THERAPY; MALE; MULTIMODALITY CANCER THERAPY; NEODYMIUM LASER; PRIORITY JOURNAL; TREATMENT OUTCOME; CARCINOMA; CLINICAL TRIAL; COHORT ANALYSIS; DIGESTIVE TRACT ENDOSCOPY; ESOPHAGUS TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; COMBINED MODALITY THERAPY; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LASER THERAPY, LOW-LEVEL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036584571     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2002.123270     Document Type: Article

References (25)

1. Blot WJ. Esophageal cancer trends and risk factors. Semi Oncol 1994;21:403-10.
2. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA Cancer J Clin 1995;45:8-30.
3. Axelrad AM, Fleischer DE. Esophageal tumors. In: Feldman M, Scharschmidt BF, Sleisenger MH, Klein S, editors. Sleisenger and Fordtrand's gastrointestinal and liver disease. Philadelphia: WB Saunders; 1998. p. 540.
4. Kelsen DP, Ginsberg R, Pajak TF, Sheaha DG, Gunderson L, Mortimer J, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Eng J Med 1998;339:1979-84.
5. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared to radiotherapy alone in patients with cancer of the esophagus. N Eng J Med 1992;326:1593-8.
6. Ilson DH, Kelsen DP. Combined modality therapy in the treatment of esophageal cancer. Semin Oncol 1994;21:493-507.
7. Kelsen DP, Ilson DH. Chemotherapy and combined modality for esophageal cancer. Chest 1995;107(Suppl)224S-232S.
8. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultgorn R, Jokobsen A, et al. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-10.
9. Walsh TN, Noonal N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodality therapy and surgery for esophageal adenocarcinoma. N Eng J Med 1996; 335:462-7.
10. Bourke MJ, Hope RLH, Chu G, Gillespie PE, Bull C, O'Rourke I, et al. Laser palliation of inoperable malignant dysphagia: initial and at death. Gastrointest Endosc 1996;43:29-32.
11. Abdel-Wahab M, Gad-Elhak N, Denewer A, El-Ebidy G, Sultan A, Abou-Elenin A, et al. Endoscopic laser treatment of progressive dysphagia in patients with advanced esophageal carcinoma. Hepatogastroenterology 1998;45:1509-15.
12. Maciel J, Barbosa J, Leal AS. Nd-YAG laser as a palliative treatment for malignant dysphagia. Eur J Surg Oncol 1996;22:69-73.
13. Hong MK, Reilly H, Lipman TO, Wadleigh R. Simultaneous triple therapy (chemo/radiation/laser for esophageal squamous cell carcinoma (ESCCA) increases the complete response rate: preliminary results (abstract). Gastroenterology 1996;110:A531.
14. Lipman TO, Mayoral W, Sallout H, Carroll J, Wadleigh R, Reilly M, et al. Endoscopic Nd-YAG laser-enhanced intensive multimodality therapy for advanced esophageal cancer: a 4 year experience (abstract). Gastroenterology 1999;116:A455.
15. Alexander EP, Lipman T, Harmon J, Wadleigh R. Aggressive multimodality therapy for stage III esophageal cancer: a phase I/II study. Ann Thorac Surg 2000;69:363-8.
16. American Joint Commission on Cancer. In: Beahrs OH, Heusen DE, Hutter RV, Myers MH, editors. Manual for staging cancer. 3rd ed. Philadelphia: Lippincott; 1988. p. 63-5.
17. Dose specification for reporting external beam therapy with photons and electrons. ICRU Report 29. Washington, D.C.: International Commission on Radiation Unit and Measurements; 1978.
18. Ajani JA. Contribution of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 1994;21:474-82.
19. Grem JL. 5-Fluoropyrimidines. In: Chabner BA, Longo DL, editors. Cancer chemotherapy and biotherapy: principles and practice. 2nd ed. Philadelphia: Lippincott-Raven; 1996. p. 149-211.
20. Spencer GM, Thorpe SM, Sargeant IR, Blackman GM, Salono J, Tobias JS, et al. Laser and brachytherapy in the palliation of adenocarcinoma of the oesophagus and cardia. Gut 1996; 39:726-31.
21. Shmueli E, Srivastava E, Dawes PJ, Claque M, Matthewson K, Record CO. Combination of laser treatment and intraluminal radiotherapy for malignant dysphagia. Gut 1996;38:803-5.
22. Tan CC, Freeman JG, Holmes GK, Benghiat A. Laser therapy combined with brachytherapy for the palliation of malignant dysphagia. Singapore Med J 1998;39:202-7.
23. Sargeant IR, Tobias JS, Blackman G, Thorpe S, Glover JR, Bown SG. Radiotherapy enhances laser palliation of malignant dysphagia: a randomized study. Gut 1997;40:362-9.
24. Luketich J, Christie N, Nguyen N, Keenan R, Fernando H, Ferson P, et al. Preliminary experience using photodynamic therapy as a nutritional bridge to esophagectomy in patients with esophageal cancer (abstract). J Parent Enteral Nutr 2000;24:S6-7.
25. Maier A, Anegg U, Fell B, Tomaselli F, Sankin O, Pretoenhofer V, et al. Effect of photodynamic therapy in a multimodal approach for advanced carcinoma of the gastroesophageal junction. Lasers Sing Med 2000;26:461-6.